The Impact of COVID-19 on HIV Clinical Practice

SARS-COV-2 is an RNA virus from the coronavirus family, the causative agent of COVID-19.

With nearly 6,000,000 cases worldwide, 365,000 deaths and detection in at least well over 200 countries, it continues to evolve with devastating medical and socio-economic sequelae.

The challenge with this virus is that the global population has no underlying immunity since it is novel and much about SARS-CoV-2 unknown. Likely zoonotic transmission occurred from infected bats to an intermediate host mammal which is believed to be a Pangolin. Symptoms of COVID-19 are non-specific and the disease presentation can range from no symptoms (asymptomatic/pre-symptomatic) to severe pneumonia and death.